clinical trial · NCT07089121
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia GravisJuvenile DermatomyositisDescartes-08
brief summary
Safety, tolerability and efficacy of Descarte-08 in children, adolescents and young adults with childhood-onset systemic lupus erythematosus, ANCA-associated vasculitis, juvenile myasthenia gravis, and juvenile dermatomyositis
started
Jan 14, 2026
primary completion
Dec 1, 2027
completion
Dec 1, 2028
last updated
Apr 8, 2026
official title
Descartes-08 for Children, Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus, ANCA-associated Vasculitis, Juvenile Myasthenia Gravis, and Juvenile Dermatomyositis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol